Israel Innovation Authority

20/10/2026

Israel’s tech sector raised $8.2 billion in 2025. R&D spending reached 5.6% of GDP, the highest ratio among OECD nations. Cybersecurity exports hit $17.5 billion. AI startups are on track to represent 35% of all new Israeli tech ventures by 2026, up from 22% three years ago.

The picture isn’t one-dimensional. Late-stage funding has become harder to secure, global tech companies are competing aggressively for Israeli talent, and founders are navigating a more demanding investment environment than they were two years ago. New hubs are also emerging beyond Tel Aviv. Beersheba in cybersecurity, Jerusalem in biomedical tech, the Negev in climate, Haifa in maritime and logistics.

What hasn’t changed is the depth of the ecosystem. Strong universities, a dense startup culture, and genuine expertise in fields the world increasingly needs. AI, cybersecurity, climate tech, and quantum computing are where the next chapter gets written.

Read more: https://www.jpost.com/business-and-innovation/tech-and-start-ups/article-909142

Explore how Israel’s tech industry adapts to 2026 geopolitical shifts, talent competition, and AI breakthroughs, unlocking new innovation pathways.

19/10/2026

Women remain underrepresented in senior leadership and technical roles across Israel's high-tech industry, while significant salary gaps persist.

We're working to change that.

Together with the משרד העבודה, we've invested NIS 25 million in 15 programs designed to help more women enter, remain, and advance in Israel's high-tech sector.

The programs will focus on opening pathways into deep-tech careers, advancing women into senior management, supporting women returning to the workforce, and helping them progress professionally after maternity leave.

Closing these gaps is about making better use of the talent and skills that are essential to the future of Israeli high-tech.

Read more: https://www.jpost.com/business-and-innovation/tech-and-start-ups/article-911997

19/10/2026

From human tissues to 3D-printed corneas and cultivated steaks, Israeli innovators are giving the phrase "fresh off the printer" a whole new meaning.

- Alvox is developing printed human tissues to test new drugs and reduce reliance on animal testing.
- Precise Bio is advancing bioprinted corneas, with a successful transplant at Rambam Hospital.
- Prof. Tal Dvir is developing 3D-printed hearts using patients' own cells, while Prof. Shulamit Levenberg is working to integrate blood vessels into engineered tissues.
- Aleph Farms is applying tissue engineering to cultivated meat, bringing a whole new meaning to a steak made from scratch.

These developments are part of bioconvergence, a field bringing biology, engineering, and advanced technologies together to address challenges in medicine, agriculture, and food production.

At the Authority, we're supporting Israel's growing bioconvergence ecosystem, helping turn groundbreaking research into practical technologies.

More on Alvox: https://www.almog.co.il/services/alvox-bio
More on Precise Bio: https://www.precise-bio.com/contact/
More on Aleph Farms: https://aleph-farms.com/

18/10/2026

Pollination is critical to global food production, yet changing climate conditions and declining pollinator populations are making it increasingly unpredictable.

Israeli agri-tech company BloomX is developing robotic pollination systems that work alongside bees, using AI and robotics to help farmers improve crop yields and make fruit production more reliable.

Supported by the Innovation Authority, BloomX recently raised $13 million to expand its technology into new international markets, demonstrating how investment in early-stage innovation can help Israeli technologies grow into solutions for global challenges.

This is part of our broader mission to support Israeli innovation from development to commercialization and helping technologies developed in Israel reach markets around the world.

Read more here: https://www.ynetnews.com/business/article/skakpak2me

Israeli startup says its robotic pollination systems have increased fruit yields by an average of 20% on participating farms; the company plans to expand operations in Latin America and enter the US market

14/10/2026

Israel's quantum computing ecosystem is taking another step forward.

With our support, the Israeli Quantum Computing Center (IQCC) is bringing together advanced quantum hardware, high-performance computing, and software development under one roof.

Now, Israeli company Classiq Technologies is integrating its quantum software with the center's computing infrastructure, enabling researchers to develop, test, and run quantum applications across different quantum systems more efficiently.

This collaboration between Israeli technology companies, researchers, and national R&D infrastructure is helping build the foundations for the next generation of computing.

Read more here: https://quantumzeitgeist.com/classiq-quantum-code-links-israels/

Classiq provides the quantum software layer for Israel’s new Quantum Computing Center (IQCC), linking quantum code to its HPC environment.

13/10/2026

The clock is ticking on Israel’s 2026 tax incentives for new immigrants and returning residents.

With the December 31 deadline approaching, eligible professionals relocating to Israel can benefit from significant income tax exemptions, including up to NIS 1 million annually on qualifying Israeli-earned income in 2027 and 2028.

For engineers, scientists, entrepreneurs, and other skilled professionals, these incentives offer an added opportunity to build careers in one of the world’s leading innovation ecosystems.

Read more in The Jerusalem Post: https://www.jpost.com/business-and-innovation/banking-and-finance/article-911114

Israel's new 2026 aliyah tax rules offer temporary income tax breaks for new immigrants and returning residents, while requiring greater disclosure of foreign assets despite existing exemptions.

11/10/2026

3D-printed human corneas, AI-powered drug development, and dogs trained to detect cancer.

They're all examples of bioconvergence, a field that combines biology with engineering, AI, and advanced computing to develop technologies that wouldn't be possible through any one discipline alone.

In Israel, around 200 companies are already working in this space, developing everything from biochips that analyze living cells to new methods of manufacturing using biological processes.

And the potential goes well beyond healthcare, with applications in agriculture, food production, energy, and more.

In a new pharmaphorum podcast, Shai Melcer, Head of the National Bioconvergence Programme at the Innovation Authority, explores these technologies and how our national programme is supporting the growth of this emerging industry.

Listen here: https://pharmaphorum.com/rd/bioconvergence-future-human-health-shai-melcer

Shai Melcer discusses bioconvergence, a multidisciplinary research and development approach that merges technologies.

06/10/2026

Israel has spent decades building a reputation for producing startups. The harder question is whether the research, talent, and intellectual property behind them stays in Israel as they grow.

High-tech exports hit a record $85 billion in 2025, representing 58% of total exports. More than 400 multinational R&D centers operate here alongside roughly 1,500 deep-tech companies across AI, semiconductors, quantum, robotics, and life sciences. The infrastructure exists. The question is whether it deepens enough to keep innovation anchored here through the years of development that determine whether a technology becomes a global platform or gets acquired and moved elsewhere.

That's the argument at the center of a new i24NEWS English piece on Israel's transition from Startup Nation to R&D Nation.

Read more: https://www.i24news.tv/en/news/israel/technology-science/artc-from-startup-nation-to-r-d-nation-israel-s-next-technological-leap

Record exports and multibillion-dollar deals underscore Israeli high-tech’s resilience under fire. The challenge now is keeping its talent, research and intellectual property at home

05/10/2026

September marked another strong month for Israeli high-tech.

According to CTech by Calcalist Data, Israeli startups raised approximately $2.77 billion across 28 funding rounds, with investment concentrated particularly in AI, cybersecurity and the infrastructure powering the AI economy. Pasted text

Five major rounds alone accounted for $1.9 billion, nearly 70% of the month’s total, while funding extended across defense tech, healthcare, enterprise software and other sectors. Pasted text

The data points to continued international investor confidence in Israeli innovation, and to the growing role Israeli companies are playing in building not only AI applications, but the security, data and infrastructure needed for the AI era.

Read the full analysis from CTech here: https://www.calcalistech.com/ctechnews/article/ryurpyo5fl

According to CTech Data, the month’s largest deals accounted for nearly 70% of the capital raised as investors poured money into AI and cybersecurity.

04/10/2026

Israel ranks 15th globally in the 2026 Global Innovation Index and continues to lead Northern Africa and Western Asia in innovation.

Behind the ranking are several areas where Israel places #1 in the world:

- R&D expenditure, reaching 6.8% of GDP
- Business-performed R&D
- Venture capital received
- University-industry collaboration

These rankings reflect the foundations of Israel’s innovation ecosystem, where investment in R&D, access to capital, and close collaboration between academia and industry help turn scientific and technological expertise into globally competitive innovation.

Read Israel’s full WIPO profile: https://lnkd.in/eQhMphEn

The Global Innovation Index (GII) ranks world economies according to their innovation capabilities.